DocDollars

Zoll Respicardia, Inc.

MN · United States · Reporting entity ID 100000010421

Total reported 2019–2025
$4.36M
#755 of 2,960 reporting companies — 0% of all reported industry payments
$2.36M in general payments across 5,592 records, plus $1.99M in research funding across 562 records.

How it breaks down

General payments $2,363,704
Research funding $1,992,439

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Zoll Respicardia, Inc. reported $4.36M to US doctors and teaching hospitals from 2019 to 2025, ranking #755 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 5,592 general payment records and 562 research records were filed.

Common questions about Zoll Respicardia, Inc.

How much has Zoll Respicardia, Inc. paid US doctors?

Zoll Respicardia, Inc. reported $4,356,143 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,363,704 in general payments, $1,992,439 in research funding.

How does Zoll Respicardia, Inc. rank among drug and device companies?

It ranks #755 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Zoll Respicardia, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.